Counter
Page updated 8/1/09
Lymphland International Lymphedema Online
Healing Honey for Wounds
WASHINGTON, D.C. (Ivanhoe Newswire) -- Some people suffer wounds that just won't heal. To solve
the problem, doctors are going back in time to find a solution that helps heal everything from diabetic sores
to burns.

Josh Pennington has mowed the lawn more times in his 63 years than he can count, but the routine chore
nearly killed him when he hit a stone that wounded his leg. That wound just wouldn't heal.

"I do a lot of hunting and fishing outdoors where I could possibly get it infected, so that was always on my
mind," Pennington told Ivanhoe.

His wound was so deep, it exposed his bone -- and nothing he tried for three years would fix it. To solve the
problem, doctors at Georgetown University tried a new bandage infused with honey.

"As long as it's clean and it's healthy and it's showing progress, I'm with the program," Pennington said.

Medi-Honey is a highly-absorbent, seaweed-based bandage soaked with a special kind of honey produced
only in Australia and New Zealand. The honey is concentrated and provides an ideal environment for wound
healing.

"It kills bacteria with some of the enzymes it has in it," Christopher Attinger, M.D.,
Chairman of the Division of Wound Healing at Georgetown University Hospital in Washington, D.C., told
Ivanhoe.

The acid in the bandage also helps lower the pH level in chronic wounds for better healing. Unlike
antibiotics, the honey poses no toxic effects or risks of resistance.

"We're starting to use manuka honey as a first-line drug as opposed to waiting to see whether other
dressings work, because we've had excellent success with it," Dr. Attinger said.

In just months, Pennington's wound shrunk 95 percent.

"Power to the bees," Pennington said.

He couldn't be happier that this sweet new treatment gave him his life and use of his leg back.

Researchers believe the Medi-Honey bandage may also protect wounds from infections like MRSA. A box
of the bandages costs $50.


FOR MORE INFORMATION, PLEASE CONTACT:

Division of Wound Healing
Georgetown University Hospital
Washington, D.C.
(202) 444-3059

http://www.ivanhoe.com/channels/p_channelstory.cfm?storyid=20176

-----------------------------------------------------------


Zapping Migraines



COLUMBUS, Ohio (Ivanhoe Newswire) -- About 28 million Americans suffer from migraines. The
debilitating headaches disrupt lives and force many to rely on powerful pain medications. Now a new
technique zaps away pain before it starts using a migraine magnet.

It happens at the worst times.

"Migraines are pretty inconvenient for me," Richard Higgins told Ivanhoe.

Higgins has suffered from migraines since he was a kid. Now the biomedical engineer often gets them at
work.

"My first symptoms are auras, which are small blind spots in my vision, and over the course of 10 to 15
minutes that blind spot grows so much so that I can't read or I can't drive safely," Higgins described.

There may be a way to relieve his pain without medication.

"This is a very exciting and important option," Yousef Mohammad, M.D., M.Sc., a professor of neurology
at Ohio State University Medical Center in Columbus, told Ivanhoe.

It's called a transcranial magnetic stimulator or TMS.

"They'll put it at the back of their head and they'll receive two pulses," Dr. Mohammad explained.

The device sends magnetic pulses during the aura phase -- the warning period before the migraine hits. It's
often described as an electrical storm.

"We're interrupting this electrical storm or current in the brain before it leads to the headache," Dr.
Mohammad said.

Research shows 39 percent of patients were pain-free two hours after the treatment compared to twenty-
two percent who got sham pulses. Higgins eagerly joined the TMS trial, hoping to find a replacement for
pain killers.

"Using a device that can disrupt my migraine without taking medicine, I think is for me a much safer way to
deal with the symptoms," he said.

With a job that requires his full attention, Higgins can't afford to let his migraines win.

According to Dr. Mohammad, the TMS device could approved in the next few months. If approved, it will
probably be much smaller than the one used in the research trials. Women are three times more likely to
suffer from migraines than men.



FOR MORE INFORMATION, PLEASE CONTACT:

Ohio State University Medical Center
Sheri Kirk, Medical Center Communications
(614) 293-3737
Sheri.Kirk@osumc.edu

http://www.ivanhoe.com/channels/p_channelstory.cfm?storyid=20233


------------------------------------------------------

http://www.ivanhoe.com/channels/p_channelstory.cfm?storyid=20237


Medicine's Next Big Thing: Growing New Cartilage for Knees?


PROVIDENCE, R.I. (Ivanhoe Newswire) -- Bending down or getting up can be a painful chore for
someone with knee problems. Doctors say many times the loud creaking in a person's bones can be blamed
on a loss of cartilage, but researchers are close to finding a permanent solution. They're helping the body
heal itself by naturally re-growing cartilage.

Getting down to her granddaughter's level is difficult for 60-year-old Kathleen Haberstroh.

"It hurts," she described to Ivanhoe. "It shoots up and down my leg and I can actually hear the bones
grinding."

Thomas Webster, Ph.D., a biomedical engineer at Brown University in Providence, R.I., developed a
solution that could soon help people like Haberstroh naturally regenerate cartilage in their own bodies.

"We developed a material that serves as a band-aid that can be put in the place of the degenerated
cartilage," Dr. Webster explained to Ivanhoe.

He created molecular-scale tubes made of carbon that would be implanted in a person's knee. The tubes'
rough surfaces are similar to natural tissue, which attracts cartilage-growing cells.

"We're more or less tricking the body into thinking we're implanting part of itself," Dr. Webster said.

Every time a person takes a step, the pressure on the tubes generates electricity. That current triggers the
cells to grow cartilage.

"Cells which are residing on the material can feel and sense and grow much more effectively than without
that electrical property," Dr. Webster said.

The goal: produce new cartilage and help Haberstroh play without pain.

"It would make things a lot happier because I wouldn't be left out a lot," Haberstroh said.

It could be a permanent solution for those who don't want to miss a moment of the action.

Dr. Webster and his team are still testing the cartilage regeneration procedure. Right now doctors inject an
artificial gel to imitate cartilage in the knee, but that's only a temporary solution requiring follow-up injections.



FOR MORE INFORMATION, PLEASE CONTACT:

Thomas Webster, Brown University
(401) 863-2318
Thomas_Webster@brown.edu

-----------------------------------------------------------------------------------------

stress and your immune system, quiz on how emotions affect your immunity

Stress: Your Body Under Attack
by Anita Harris
Having trouble sleeping? Popping more antacids than usual? Or maybe you've had more colds this winter.
Maybe these symptoms are related to stress.
Just about everyone has experienced a pounding heart, tense muscles, and sweaty palms—the body's
evolutionary "fight or flight" response when facing a threat.
It's a well-known phenomenon that a certain amount of stress can sharpen your mental prowess, and new
research suggests that brief exposures to certain stressors may enhance the body's immune response.
However, responses designed by evolution to protect us from predators may sometimes be useful, says
Richard Sloan, PhD, director of the Department of Behavioral Medicine at the Columbia Presbyterian
Medical Center in New York. They are counterproductive in many situations today.
Your Body Under Stress
When you experience stress, Sloan explains, your blood clots more readily so you bleed less, and blood
flows to your muscles so you can fight back with strength. This would be very helpful if you were being
attacked by a lion, he says, "but it's not useful when your boss yells at you." According to some studies,
prolonged or frequent exposure to stressful events might increase our vulnerability to illnesses like
depression, heart attacks, and the common cold.
Scientists are only just beginning to understand how this works, according to Firdaus Dhabhar, PhD, an
assistant professor and neuroimmunologist at Ohio State University.
As he explains it, when our sensory organs encounter a potential threat, they transmit signals to the brain
which, in turn, releases chemicals that stimulate nerves and glands throughout the body. In the adrenal
glands—which are located near the kidneys—the brain chemicals induce the secretion of the hormones
corticosterone and epinephrine, which stimulate the organs to act in various ways.
The result is what Dhabhar calls "the typical stress response":
The heart beats faster.
The muscles tense.
Sweat glands are activated.
Blood flow is diverted from the intestines to other parts of the body.
Immune cells move from the blood to other organs.
Ordinarily, Dhabhar says, within three hours following the threat, "Everything goes back to normal."
The Dangers of Chronic Stress
Under conditions of ongoing or repeated stress—such as continual worry and anxiety, a bad work situation,
or medical illness—the body's "fight or flight" system gets "hammered," Dhabhar says. Constant stimulation
might lead to overproduction of stress-related hormones and "the systems begin to break down." This, in
time, could negatively affect the immune system.
According to Herbert Benson, MD, chief of the Division of Behavioral Medicine at Beth Israel Deaconess
Medical Center in Boston, chronic stress can lead to the following:
Depression
Anger
High blood pressure
Cardiac arrhythmia
Insomnia
Atherosclerosis
Infertility
Chronic stress might also increase the risk of heart attacks and make premenstrual syndrome and hot flashes
more severe. Recent research suggests that high levels of stress might speed up the progression of AIDS
and multiple sclerosis, and hinder the effects of medication.
Crying Wolf
Repeated or constant exposure to stressors may also impair the brain's ability to evaluate whether a stress
response is warranted and make it less able to regulate the response, according to a 1998 article in the New
England Journal of Medicine by Bruce McEwen, PhD, of the Rockefeller Institute. This could be
problematic at several levels—from the day-to-day management of average stressors to suddenly being
faced with a situation that would normally call up the fight or flight response.
Recognizing There's a Problem
To begin with, it's important to recognize the presence of stress-induced symptoms. The signs may include
the following:
Excess anxiety
Stomachaches
Headaches
Diarrhea
Temper outbursts
Unexplained anger or crying spells
Nightmares or insomnia
Personality changes
Impatience
Reducing the Stress
Change your situation
Do what you can to change stressful conditions, Benson advises. If they involve a relationship or workplace
situation, he says, "more often than not, this is difficult to do."
Learn to relax
Benson advocates invoking what he calls "the relaxation response". This well-known technique, based on
the principles of transcendental meditation, involves repeating a word, sound, prayer or phrase or
performing a repetitive muscular activity.
"When other thoughts come into your mind, let them go passively, and come back to repetition." According
to Benson, who is the founder of the Mind/Body Medical Institute, these activities have been shown to quiet
the brain and to decrease blood pressure, heart rate, and the rate of breathing.
Change your outlook
Sloan suggests learning relaxation techniques such as biofeedback, and what he terms "cognitive
restructuring," a method that involves questioning whether the physiologic reaction you are experiencing is
rationally justified.
"You may learn that your office is being moved and think 'that's the worst news I've had in years,'" he
explains. By "reforming" the issue, you may decide it's not so bad—and your body will respond accordingly.
Practice remaining calm
Sloan also suggests rehearsing in advance how you will respond to a stressful situation. For example, if you
need to deal with a difficult person, "figure out how you will address your concerns without yelling or
provoking an angry attack and then practice these behaviors."
Seek help
Others suggest developing a network of family and friends to avoid social isolation, and seeking professional
counseling if needed.
Keep it simple
In Dhabhar's view, "Grandma's advice still stands." You should "eat good, wholesome food; exercise
moderately and get enough sleep." This may seem "too simple," he says, but being in a state of healthy
equilibrium helps you minimize the impact of stress and makes your body better able to fend off any immune
challenges that arise.


RESOURCES:
American Institute of Stress
http://www.stress.org
Mind/Body Medical Institute
http://www.mbmi.org/Default.asp
Stress Management Briefs from the University of Minnesota
http://www.extension.umn.edu/distribution/familydevelopment/DE7269.html

========================================================


Basal Body Temperature and Thyroid Function

Thyroid hormone is secreted from a gland in the area of the “Adam's apple” and helps regulate the entire
body's activity level (metabolism). Low body temperatures can be a sign of decreased metabolism. This can
be caused by thyroid imbalances as well as other hormonal and nutritional problems. Lab studies often miss
thyroid problems that aren't immediately life-threatening. By checking your axillary temperature (under the
arm) every morning you can see if your metabolism is running at its peak.
Shake your mercury thermometer down in the evening within arm's reach of your bed.
Upon awakening in the morning (before getting out of bed) place the thermometer under your armpit.
Remain very still and read the temperature at 10 minutes.
Record the temperature for 10 different days.
At the completion of your 10-day cycle add all the temperatures and divide by 10. If your average
temperature is below 97.5 degrees Fahrenheit it is probable that you will benefit from thyroid evaluation and
treatment. This type of evaluation is best understood by doctors who specialize in functional, holistic,
alternative or integrative medicine. More information on this concept is available at
www.brodabarnes.org

============================================================

What is irritable bowel syndrome (IBS)?
Irritable bowel syndrome is a disorder characterized most commonly by cramping, abdominal pain, bloating,
constipation, and diarrhea. IBS causes a great deal of discomfort and distress, but it does not permanently
harm the intestines and does not lead to a serious disease, such as cancer. Most people can control their
symptoms with diet, stress management, and prescribed medications. For some people, however, IBS can
be disabling. They may be unable to work, attend social events, or even travel short distances.

What are the symptoms of IBS?
Abdominal pain, bloating, and discomfort are the main symptoms of IBS. However, symptoms can vary
from person to person. Some people have constipation, which means hard, difficult-to-pass, or infrequent
bowel movements. Often these people report straining and cramping when trying to have a bowel movement
but cannot eliminate any stool, or they are able to eliminate only a small amount. If they are able to have a
bowel movement, there may be mucus in it, which is a fluid that moistens and protect passages in the
digestive system. Some people with IBS experience diarrhea, which is frequent, loose, watery, stools.
People with diarrhea frequently feel an urgent and uncontrollable need to have a bowel movement. Other
people with IBS alternate between constipation and diarrhea. Sometimes people find that their symptoms
subside for a few months and then return, while others report a constant worsening of symptoms over time.



What causes IBS?
Researchers have yet to discover any specific cause for IBS. One theory is that people who suffer from IBS
have a colon, or large intestine, that is particularly sensitive and reactive to certain foods and stress. The
immune system, which fights infection, may also be involved.



Normal motility, or movement, may not be present in the colon of a person who has IBS. It can be
spasmodic or can even stop working temporarily. Spasms are sudden strong muscle contractions that come
and go.

The lining of the colon called the epithelium, which is affected by the immune and nervous systems, regulates
the flow of fluids in and out of the colon. In IBS, the epithelium appears to work properly. However, when
the contents inside the colon move too quickly, the colon loses its ability to absorb fluids. The result is too
much fluid in the stool. In other people, the movement inside the colon is too slow, which causes extra fluid
to be absorbed. As a result, a person develops constipation.

A person’s colon may respond strongly to stimuli such as certain foods or stress that would not bother most
people.

Recent research has reported that serotonin is linked with normal gastrointestinal (GI) functioning. Serotonin
is a neurotransmitter, or chemical, that delivers messages from one part of your body to another. Ninety-five
percent of the serotonin in your body is located in the GI tract, and the other 5 percent is found in the brain.
Cells that line the inside of the bowel work as transporters and carry the serotonin out of the GI tract.
People with IBS, however, have diminished receptor activity, causing abnormal levels of serotonin to exist in
the GI tract. As a result, they experience problems with bowel movement, motility, and sensation—having
more sensitive pain receptors in their GI tract.

Researchers have reported that IBS may be caused by a bacterial infection in the gastrointestinal tract.
Studies show that people who have had gastroenteritis sometimes develop IBS, otherwise called post-
infectious IBS.

Researchers have also found very mild celiac disease in some people with symptoms similar to IBS. People
with celiac disease cannot digest gluten, a substance found in wheat, rye, and barley. People with celiac
disease cannot eat these foods without becoming very sick because their immune system responds by
damaging the small intestine. A blood test can determine whether celiac disease may be present. (For
information about celiac disease, see the NIDDK’s Celiac Disease fact sheet.)


How is IBS diagnosed?
If you think you have IBS, seeing your doctor is the first step. IBS is generally diagnosed on the basis of a
complete medical history that includes a careful description of symptoms and a physical examination.

There is no specific test for IBS, although diagnostic tests may be performed to rule out other problems.
These tests may include stool sample testing, blood tests, and x rays. Typically, a doctor will perform a
sigmoidoscopy, or colonoscopy, which allows the doctor to look inside the colon. This is done by inserting a
small, flexible tube with a camera on the end of it through the anus. The camera then transfers the images of
your colon onto a large screen for the doctor to see better.

If your test results are negative, the doctor may diagnose IBS based on your symptoms, including how often
you have had abdominal pain or discomfort during the past year, when the pain starts and stops in relation to
bowel function, and how your bowel frequency and stool consistency have changed. Many doctors refer to
a list of specific symptoms that must be present to make a diagnosis of IBS.

Symptoms include

Abdominal pain or discomfort for at least 12 weeks out of the previous 12 months. These 12 weeks do not
have to be consecutive.

The abdominal pain or discomfort has two of the following three features:

It is relieved by having a bowel movement.
When it starts, there is a change in how often you have a bowel movement.
When it starts, there is a change in the form of the stool or the way it looks.


Certain symptoms must also be present, such as

a change in frequency of bowel movements
a change in appearance of bowel movements
feelings of uncontrollable urgency to have a bowel movement
difficulty or inability to pass stool
mucus in the stool
bloating


Bleeding, fever, weight loss, and persistent severe pain are not symptoms of IBS and may indicate other
problems such as inflammation, or rarely, cancer.

The following have been associated with a worsening of IBS symptoms

large meals
bloating from gas in the colon
medicines
wheat, rye, barley, chocolate, milk products, or alcohol
drinks with caffeine, such as coffee, tea, or colas
stress, conflict, or emotional upsets
Researchers have found that women with IBS may have more symptoms during their menstrual periods,
suggesting that reproductive hormones can worsen IBS problems.

In addition, people with IBS frequently suffer from depression and anxiety, which can worsen symptoms.
Similarly, the symptoms associated with IBS can cause a person to feel depressed and anxious.




What is the treatment for IBS?
Unfortunately, many people suffer from IBS for a long time before seeking medical treatment. Up to 70
percent of people suffering from IBS are not receiving medical care for their symptoms. No cure has been
found for IBS, but many options are available to treat the symptoms. Your doctor will give you the best
treatments for your particular symptoms and encourage you to manage stress and make changes to your diet.

Medications are an important part of relieving symptoms. Your doctor may suggest fiber supplements or
laxatives for constipation or medicines to decrease diarrhea, such as Lomotil or loperamide (Imodium). An
antispasmodic is commonly prescribed, which helps to control colon muscle spasms and reduce abdominal
pain. Antidepressants may relieve some symptoms. However, both antispasmodics and antidepressants can
worsen constipation, so some doctors will also prescribe medications that relax muscles in the bladder and
intestines, such as Donnapine and Librax. These medications contain a mild sedative, which can be habit
forming, so they need to be used under the guidance of a physician.

A medication available specifically to treat IBS is alosetron hydrochloride (Lotronex). Lotronex has been
reapproved with significant restrictions by the U.S. Food and Drug Administration (FDA) for women with
severe IBS who have not responded to conventional therapy and whose primary symptom is diarrhea.
However, even in these patients, Lotronex should be used with great caution because it can have serious
side effects such as severe constipation or decreased blood flow to the colon.

With any medication, even over-the-counter medications such as laxatives and fiber supplements, it is
important to follow your doctor’s instructions. Some people report a worsening in abdominal bloating and
gas from increased fiber intake, and laxatives can be habit forming if they are used too frequently.

Medications affect people differently, and no one medication or combination of medications will work for
everyone with IBS. You will need to work with your doctor to find the best combination of medicine, diet,
counseling, and support to control your symptoms.




How does stress affect IBS?
Stress—feeling mentally or emotionally tense, troubled, angry, or overwhelmed—can stimulate colon
spasms in people with IBS. The colon has many nerves that connect it to the brain. Like the heart and the
lungs, the colon is partly controlled by the autonomic nervous system, which responds to stress. These
nerves control the normal contractions of the colon and cause abdominal discomfort at stressful times.
People often experience cramps or “butterflies” when they are nervous or upset. In people with IBS, the
colon can be overly responsive to even slight conflict or stress. Stress makes the mind more aware of the
sensations that arise in the colon, making the person perceive these sensations as unpleasant.

Some evidence suggests that IBS is affected by the immune system, which fights infection in the body. The
immune system is affected by stress. For all these reasons, stress management is an important part of
treatment for IBS. Stress management options include

stress reduction (relaxation) training and relaxation therapies such as meditation
counseling and support
regular exercise such as walking or yoga
changes to the stressful situations in your life
adequate sleep




What does the colon do?
The colon, which is about 5 feet long, connects the small intestine to the rectum and anus. The major
function of the colon is to absorb water, nutrients, and salts from the partially digested food that enters from
the small intestine. Two pints of liquid matter enter the colon from the small intestine each day. Stool volume
is a third of a pint. The difference between the amount of fluid entering the colon from the small intestine and
the amount of stool in the colon is what the colon absorbs each day.

Colon motility—the contraction of the colon muscles and the movement of its contents—is controlled by
nerves, hormones, and impulses in the colon muscles. These contractions move the contents inside the colon
toward the rectum. During this passage, water and nutrients are absorbed into the body, and what is left
over is stool. A few times each day contractions push the stool down the colon, resulting in a bowel
movement. However, if the muscles of the colon, sphincters, and pelvis do not contract in the right way, the
contents inside the colon do not move correctly, resulting in abdominal pain, cramps, constipation, a sense of
incomplete stool movement, or diarrhea.




Can changes in diet help IBS?
For many people, careful eating reduces IBS symptoms. Before changing your diet, keep a journal noting
the foods that seem to cause distress. Then discuss your findings with your doctor. You may want to consult
a registered dietitian who can help you make changes to your diet. For instance, if dairy products cause your
symptoms to flare up, you can try eating less of those foods. You might be able to tolerate yogurt better than
other dairy products because it contains bacteria that supply the enzyme needed to digest lactose, the sugar
found in milk products. Dairy products are an important source of calcium and other nutrients. If you need to
avoid dairy products, be sure to get adequate nutrients in the foods you substitute, or take supplements.

In many cases, dietary fiber may lessen IBS symptoms, particularly constipation. However, it may not help
with lowering pain or decreasing diarrhea. Whole grain breads and cereals, fruits, and vegetables are good
sources of fiber. High-fiber diets keep the colon mildly distended, which may help prevent spasms. Some
forms of fiber keep water in the stool, thereby preventing hard stools that are difficult to pass. Doctors
usually recommend a diet with enough fiber to produce soft, painless bowel movements. High-fiber diets
may cause gas and bloating, although some people report that these symptoms go away within a few weeks.
(For information about diets for people with celiac disease, please see the NIDDK’s Celiac Disease fact
sheet.) Increasing fiber intake by 2 to 3 grams per day will help reduce the risk of increased gas and bloating.

Drinking six to eight glasses of plain water a day is important, especially if you have diarrhea. Drinking
carbonated beverages, such as sodas, may result in gas and cause discomfort. Chewing gum and eating too
quickly can lead to swallowing air, which also leads to gas.

Large meals can cause cramping and diarrhea, so eating smaller meals more often, or eating smaller
portions, may help IBS symptoms. Eating meals that are low in fat and high in carbohydrates such as pasta,
rice, whole-grain breads and cereals (unless you have celiac disease), fruits, and vegetables may help.




Is IBS linked to other health problems?
As its name indicates, IBS is a syndrome—a combination of signs and symptoms. IBS has not been shown
to lead to a serious disease, including cancer. Through the years, IBS has been called by many names,
among them colitis, mucous colitis, spastic colon, or spastic bowel. However, no link has been established
between IBS and inflammatory bowel diseases such as Crohn’s disease or ulcerative colitis.




Points to Remember
IBS is a disorder that interferes with the normal functions of the colon. The symptoms are crampy abdominal
pain, bloating, constipation, and diarrhea.

IBS is a common disorder found more often in women than men.

People with IBS have colons that are more sensitive and reactive to things that might not bother other
people, such as stress, large meals, gas, medicines, certain foods, caffeine, or alcohol.

IBS is diagnosed by its signs and symptoms and by the absence of other diseases.

Most people can control their symptoms by taking medicines such as laxatives, antidiarrhea medicines,
antispasmodics, or antidepressants; reducing stress; and changing their diet.

IBS does not harm the intestines and does not lead to cancer. It is not related to Crohn’s disease or
ulcerative colitis.



Hope through Research
The NIDDK conducts and supports research into many kinds of digestive disorders including IBS.
Researchers are studying gastrointestinal motility and sensitivity to find possible treatments for IBS. These
studies include the structure and contraction of gastrointestinal muscles, as well as the mechanics of fluid
movement through the intestines. Understanding the influence of the nerves, hormones, and inflammation in
IBS may lead to new treatments to better control the symptoms.

The U.S. Government does not endorse or favor any specific commercial product or company. Trade,
proprietary, or company names appearing in this document are used only because they are considered
necessary in the context of the information provided. If a product is not mentioned, the omission does not
mean or imply that the product is unsatisfactory.



For More Information
International Foundation for Functional Gastrointestinal Disorders
P.O. Box 170864
Milwaukee, WI 53217–8076
Phone: 1–888–964–2001
Fax: 414–964–7176
Email: iffgd@iffgd.org
Internet: www.iffgd.org


============================================================

What is Peripheral Neuropathy?


Peripheral neuropathy describes damage to the peripheral nervous system, which transmits information from
the brain and spinal cord to every other part of the body.

More than 100 types of peripheral neuropathy have been identified, each with its own characteristic set of
symptoms, pattern of development, and prognosis. Impaired function and symptoms depend on the type of
nerves -- motor, sensory, or autonomic -- that are damaged.  Some people may experience temporary
numbness, tingling, and pricking sensations, sensitivity to touch, or muscle weakness. Others may suffer
more extreme symptoms, including burning pain (especially at night), muscle wasting, paralysis, or organ or
gland dysfunction. Peripheral neuropathy may be either inherited or acquired. Causes of acquired peripheral
neuropathy include physical injury (trauma) to a nerve, tumors, toxins, autoimmune responses, nutritional
deficiencies, alcoholism, and vascular and metabolic disorders. Acquired peripheral neuropathies are caused
by systemic disease, trauma from external agents, or infections or autoimmune disorders affecting nerve
tissue. Inherited forms of peripheral neuropathy are caused by inborn mistakes in the genetic code or by new
genetic mutations.


Is there any treatment?


No medical treatments exist that can cure inherited peripheral neuropathy. However, there are therapies for
many other forms.  In general, adopting healthy habits -- such as maintaining optimal weight, avoiding
exposure to toxins, following a physician-supervised exercise program, eating a balanced diet, correcting
vitamin deficiencies, and limiting or avoiding alcohol consumption -- can reduce the physical and emotional
effects of peripheral neuropathy.  Systemic diseases frequently require more complex treatments.


What is the prognosis?


In acute neuropathies, such as Guillain-Barré syndrome, symptoms appear suddenly, progress rapidly, and
resolve slowly as damaged nerves heal. In chronic forms, symptoms begin subtly and progress slowly. Some
people may have periods of relief followed by relapse. Others may reach a plateau stage where symptoms
stay the same for many months or years. Some chronic neuropathies worsen over time, but very few forms
prove fatal unless complicated by other diseases. Occasionally the neuropathy is a symptom of another
disorder.


What research is being done?


The National Institute of Neurological Disorders and Stroke (NINDS) and other institutes of the National
Institutes of Health (NIH) conduct research related to peripheral neuropathies in laboratories at the NIH and
also support additional research through grants to major medical institutions across the country.  Current
research projects funded by the NINDS involve investigations of genetic factors associated with hereditary
neuropathies, studies of biological mechanisms involved in diabetes-associated neuropathies, and
investigations exploring how the immune system contributes to peripheral nerve damage.  Neuropathic pain
is a primary target of NINDS-sponsored studies aimed at developing more effective therapies for symptoms
of peripheral neuropathy. Some scientists hope to identify substances that will block the brain chemicals that
generate pain signals, while others are investigating the pathways by which pain signals reach the brain.


Select this link to view a list of studies currently seeking patients.

Organizations

American Chronic Pain Association (ACPA)
P.O. Box 850
Rocklin, CA   95677-0850
ACPA@pacbell.net
http://www.theacpa.org
Tel: 916-632-0922 800-533-3231
Fax: 916-632-3208

Neuropathy Association
60 East 42nd Street
Suite 942
New York, NY   10165-0999
http://www.neuropathy.org
Tel: 212-692-0662
Fax: 212-692-0668


National Foundation for the Treatment of Pain
P.O. Box 70045
Houston, TX   77270
http://www.paincare.org
Tel: 713-862-9332
Fax: 713-862-9346

American Pain Foundation
201 North Charles Street
Suite 710
Baltimore, MD   21201-4111
http://www.painfoundation.org
Tel: 888-615-PAIN (7246)
Fax: 410-385-1832


National Kidney & Urologic Diseases Information Clearinghouse (NKUDIC)
3 Information Way
Bethesda, MD   20892-3580
http://www.niddk.nih.gov
Tel: 301-654-4415 800-891-5390

Charcot-Marie-Tooth Association (CMTA)
2700 Chestnut Parkway
Chester, PA   19013-4867
http://www.charcot-marie-tooth.org
Tel: 610-499-9264 800-606-CMTA (2682)
Fax: 610-499-9267


Muscular Dystrophy Association
3300 East Sunrise Drive
Tucson, AZ   85718-3208
http://www.mda.org
Tel: 520-529-2000 800-344-4863
Fax: 520-529-5300

American Diabetes Association
1701 North Beauregard Street
Alexandria, VA   22311  
http://www.diabetes.org
Tel: 800-DIABETES (342-2383) 703-549-1500


National Diabetes Information Clearinghouse (NDIC)
1 Information Way
Bethesda, MD   20892-3560  
http://www.diabetes.niddk.nih.gov
Tel: 301-654-3327 800-860-8747


Prepared by:
Office of Communications and Public Liaison
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, MD 20892


NINDS health-related material is provided for information purposes only and does not necessarily represent
endorsement by or an official position of the National Institute of Neurological Disorders and Stroke or any
other Federal agency. Advice on the treatment or care of an individual patient should be obtained through
consultation with a physician who has examined that patient or is familiar with that patient's medical history.

All NINDS-prepared information is in the public domain and may be freely copied. Credit to the NINDS or
the NIH is appreciated.

http://www.ninds.nih.gov/disorders/peripheralneuropathy/peripheralneuropathy.htm

Peripheral Neuropathy: Tingling or Numbness of the Hands and/or Feet


Presented by:
Nessa Coyle, NP, PhD, FAAN
and
K. Simon Yeung, PhamD, LAc
August 7, 2007

Treatment for cancer may be followed by numbness, tingling, or weakness in some parts of the body. These
symptoms may range from distressing to disabling and can affect quality of life. Please join us for an in-depth
discussion of this troubling disorder.
http://www.mskcc.org/mskcc/html/75594.cfm#395441


==============================================================



COMPLEX REGIONAL PAIN SYNDROME (CRPS)
aka REFLEX SYMPATHETIC DYSTROPHY (RSDS)
RSD is also known as Complex Regional Pain Syndrome (CRPS) type 1. CRPS type 2 is causalgia which
is identical to type 1 except that it is caused by a nerve lesion. Recent evidence suggests that CRPS1 is also
from nerve damage.(Please see "Evidence of Nerve Damage in CRPS1" on WHAT'S NEW? page).
Other names:
causalgia
algodystrophy
postraumatic dystrophy
Sudeck's atrophy
shoulder-hand syndrome

RSD/CRPS has existed since the American Civil War (1861-5) where Dr. Silas Weir Mitchell documented
cases of causalgia in Civil War soldiers.
RSD/CRPS is a multi-system syndrome with diverse symptoms characterized by chronic pain. Usually it
affects one or more extremities but it can affect any part of the body. Due to dilation or constriction of the
blood vessels, the blood supply to the limb (hand, foot, hip, shoulder) is affected. The nerves, skin, muscle
and bone are also involved.
RSD is a debilitating disease which can impair the ability of the limb to function or function can be lost.

How do you get RSD/CRPS?
a soft tissue injury due to minor trauma in 65% of cases e.g. sprain, twisted ankle etc.
fracture
surgery
certain cervical spine or spinal cord disorders
infections, stroke, heart attack, repetitive motion disorder, or cumulative trauma e.g.. carpal tunnel.
certain medications or venipuncture in rare cases
What are the symptoms?
PAIN usually burning, severe, constant and in an area other than the primary injury site
SWELLING usually localized but can involve entire limb
SKIN CHANGES: TEMPERATURE or COLOUR: E.G. dystrophy, dryness, tissue atrophy e.g.. can be
cool and pallid or mottled; or warm and red with increased sweating.
LIMITED AROM (active range of motion) in the affected part
INCREASE OF ABOVE COMPLAINTS after exercise
What other symptoms are there?
motor dysfunction e.g. tremor, weakness, dystonia, spasms
dystrophy e.g. muscle wasting
limbic system dysfunction e.g.. insomnia, agitation, anxiety, depression, poor memory or judgment
hair and nail changes
bone changes e.g.. osteoporosis
joint tenderness and swelling
How is it diagnosed?
There is NO SINGLE TEST available to diagnose RSD/CRPS.
thorough medical history noting sign and symptoms
examination by a qualified expert physician
thermography which measures the heat emitted from the body and senses skin temperature differences (may
help)

DO YOU SUSPECT RSD?
"If the pain is out of proportion to the injury, there is stiffness and inflammation following a seemingly minor
trauma e.g. twisted ankle, dropping item on foot, sprain , suspect RSD. The pain is described as burning,
shooting, stabbing or a "hot poker". If the pain persists longer than the expected healing time of the injury,
suspect RSD."
(from: Hooshmand, H MD CRPS: Diagnosis and Management Pain Digest Spring Verlager 1999).

---------------------------------------------------------------------------------

TREATMENT IS CRUCIAL WITHIN THE FIRST THREE TO SIX MONTHS when the disease
responds best. It is essential that the person be referred to the proper specialist for treatment as soon as
possible. After 6 months you can still receive treatment however avoid delays and see a specialist as soon as
possible for best results.

DELAY IN TREATMENT COULD MEAN A LIFETIME OF CHRONIC PAIN for the patient. Without
treatment, the disease could eventually become resistant to treatment.

---------------------------------------------------------------------------------


Who can get RSD/CRPS?
Anyone can get RSD, but it is more prevalent among women 3-1 to men; typically it is a women ages 40-60
who is most affected. However, children and teenagers can have RSD as well. For them, the prognosis is
more favourable.
What can I do?
"Early diagnosis brings the best prognosis" In RSD/CRPS the best response to treatment is within the first
three to six months of the disease. If after reading this, you suspect that you or a friend may have RSD, get
treatment as soon as possible. For doctor referrals in your area, please contact us.

TREATMENT
The following is a list of treatments for RSD/CRPS:
Drug therapy: a) local or systemic corticosteroids b) muscle relaxants c) alpha-adrenergic and beta blockers
d) analgesics e) anti-inflammatories f) tricyclics and related compounds g) tranquillizers h) calcium channel
blockers i) membrane stabilizers j) opiods
Blocks: a) focal b) sympathetic blockade c) intravenous regional blocks d) epidural e)plexus catheter blocks
Physical therapy: land PT or aqua therapy
Transcutaneous electrical nerve stimulator (TENS)
Sympathectomy: a) surgical b) chemical in selected cases
Implantable devices: a) dorsal column stimulator b) peripheral nerve stimulator c) morphine infusion pump
(intrathecal drug delivery e.g. baclofen)
CURRENT RECOMMENDATIONS FOR TREATMENT
UPDATE 2006: Please contact PARC for current recommendations for treatment.
UPDATE 2004: From the San Diego Conference Sept. 11-2, 2004, are the "revised therapeutic algorithm
for CRPS with emphasis on therapeutic options in response to patient's clinical progress in the rehabilitation
pathway".(1)
Abstract: The goal of treatment in patients with complex regional pain syndrome (CRPS) is to improve
function, relieve pain and achieve remission. Current guidelines recommend interdisciplinary management,
emphasizing 3 core treatment elements: pain management, rehabilitation, and psychological therapy.
Although the best therapeutic regimen or the ideal progression through these has not yet been established,
increasing evidence suggest that some cases are refractory to conservative measures and require flexible
application of the various treatments as well as earlier consideration of such interventions such as a spinal
cord stimulator(SCS). While existing treatment guidelines have attempted to address the comprehensive
management of CRPS, all fail to provide for contingent management in response to a sudden change in the
patient’s medical status. This paper reviews the current pathophysiology as it is known, the purported
treatments, and provides a modified clinical pathway (guideline) that attempts to expand the scope of
previous guidelines.(2)
A review of this article will appear in the PARC PEARL newsletter. Please contact PARC.
(1,.2) Stanton-Hicks, Michael MD BS, DR med et al
An Updated Interdisciplinary Clinical Pathway for CRPS: Report of an Expert Panel World Institute of Pain
Pain Practice Vol. 2 No.1; 2002 1-16.

---------------------------------------------------------------------------------

2002
The doctors at the Tampa CRPS/RSD Conference in Feb. 2002 discussed the following:
Physiotherapy is the number one treatment modality which will return function to the limb, range of motion,
flexibility and strength. It is imperative that PT is part of the treatment program.
Aqua therapy is also recommended in 92-93 degree water. It is moist heat which is good for most RSD
patients, it is non-weight bearing. it supports weak muscles, and the amount of resistance can be controlled.
Warm water is also soothing.
Psychological support is also recommended e.g.. counselling, cognitive behaviour techniques, biofeedback,
visualization, relaxation techniques, hypnosis. Any of these modalities can help.
Medications that control pain are essential and will facilitate the progress made in physiotherapy.
CONSENSUS REPORT
According to the 1998 Consensus Report compiled by Michael Stanton-Hicks et al, "CRPS:Guidelines for
Therapy" states that a three pronged approach is best. The treatment algorithm has the following three
elements:
A) Medical Interventions: NSAIDS, Opioids, Tricyclics, Alpha 2 Agonists, Calcium channel Blockers. The
next phase is blocks (focal, sympathetic, regional,epidural and pumps.). Then Neurostimulation (SCS, PNS)
and medications.
B) Physical Therapy: It is essential that early intervention occur here. Progress is contingent upon the degree
of pain and successful treatment of pain. "It is critical to progress slowly and within patient defined limits....
adequate and liberal analgesia should be used to facilitate these steps.". Steps include gentle reactivation:
contrast baths, desensitization. Flexibility, edema control, peripheral E-Stim, isometric strengthening, and
most importantly diagnosis and treatment of secondary myofascial pain. Gentle ROM (range of motion
exercises), stress loading, isotonic strengthening, general aerobic conditioning, postural normalization and
balanced use can also be done. Next is ergonomics, movement therapies, normalization of use and
vocational and functional rehabilitation. Any of these methods can be used to facilitate progress in an
individual with RSD/CRPS.
C) Psychological Interventions: Various methods include counselling (expectations, motivation, control,
family, diary) behaviour therapy,relaxation techniques, imagery, hypnosis and coping skills. Any of these
methods can be used.
Methods A. B. and C are designed to work simultaneously in order to facilitate the return of function and
good pain control for the patient.
( Source: Stanton-Hicks M et al "Consensus Report: CRPS: Guidelines for Therapy" Clin Jour Pain 1998:
14; 155-66.)

PROBLEMS
If treatment is delayed, many RSD/CRPS patients can face the following:
a lifetime of chronic pain.
not being believed or misdiagnosed
receiving inappropriate treatments
dealing with doctors who are inexperienced in diagnosing and treating RSD/CRPS
Unfortunately, these situations are all too common. Most of the time, reliable information about RSD/CRPS
is the key to being believed and diagnosed properly. Receiving inappropriate treatment would not happen if
the patient and doctor were better informed. Unnecessary surgery to "correct RSD" would also not occur.
As the patient, it is possible to take on the responsibility of informing the doctor . Perhaps then, some of
these problems could be avoided. Giving the doctor as much information as you can so that he can better
treat you will certainly promote a healthy doctor-patient relationship. Working together with your doctor is a
win-win situation.


WAYS TO HELP YOUR DOCTOR
Prioritize a list of your complaints. Whatever is bothering you the most, list it first. e.g.. be specific about
where your pain is. e.g.. Before and after the visit, record pain levels throughout the day to help determine
the overall pattern of how the disease affects you.
Keep a journal of your medications. e.g. effective and non-effective medications, side effects, etc.
Be sure to take someone with you. Take notes so that you are clear as to what transpired. Another point of
view is often helpful.
Prepare a list of questions. Your spouse/friend can record the answers.
Keep a record of your past treatments and medications. Record how they affected you.
For new patients, bring your test results, scans, x-rays etc. Make a brief summary of your medical history
thus far.
OPQRST
If you are experiencing pain and are having difficulty describing it, this is a device that doctors use to
diagnose pain. It could help prepare you for your next doctor’s visit. Answers should be as clear and brief
as possible:

• ONSET: When did the pain start?
• PROVOKES: What makes it better and/or worse?
• QUALITY: What does the pain feel like? e.g. burning, throbbing
• RADIATES: Does the pain travel or stay in one place?
• SITE:Where do you feel the pain?
• TIMING: When do you get the pain? (e.g. morning, evening,) and how long does it last?
PAIN DIARY
Keep a pain diary with recorded pain levels three times per day. Divide the seven days into three parts and
record levels by assigning number to your pain:
0 = no pain
5 = moderate pain
10 = worst pain you ever had

Take this pain diary along with your other materials to your doctor.

WHY DO WE GET RSD?
There are several theories as to why we get RSD. Most of the current theories cannot fully explain all the
processes going on in the body e.g.. signs and symptoms vary from patient to patient and can be
inflammatory e.g.. pain, edema, skin and temperature changes and neurological e.g.. hyperesthesia,
hyperpathy or motor dysfunction (tremor).
The psychosocial theory states that various predisposing factors such as emotional instability, nervousness,
depression, anxiety and life events contribute to a person developing RSD. There is no evidence thus far, in
the literature to support this theory. Inactivity has also been suggested to contribute to edema and muscle
atrophy in RSD. In chronic RSD, atrophy and edema are present. However, inactivity cannot explain the
skin discoloration, altered temperature or pain. Quite popular even still, is the sympathetic theory which
states that an hyperactive sympathetic nervous system is responsible for RSD. Since sweating and
vasomotor instability are present and a sympathectomy reduces pain, this theory was thought to hold water.
However, it did not explain why some sympathectomies did not work. None fully explained the enigma of
RSD. The causalgia theory stated that the burning sensations in RSD were caused by a nerve injury.
However, not all RSD had an nerve injury as the cause. In many cases, fracture, or soft tissue injury was the
trigger for RSD and no definable nerve lesion could be found.
Based on Sudeck's exaggerated inflammatory response theory, the signs and symptoms of inflammation and
acute RSD have similarities: "rubor (redness), calor (warmth), dolor (pain), tumor (swelling) and functio
laesa (limited function)". Based on Sudeck's theory Dr. Veldman, Dr L van der Laan and numerous other
Dutch doctors have done extensive studies with RSD/CRPS patients in Holland. They hypothesize that after
an injury or surgery there is an exaggerated inflammatory reaction process which begins in the body. Based
on a 1993 study of 829 patients over 8 years, Dr Veldman found that the most common signs and
symptoms of pain (92%), swelling (86%), difference in skin temperature (98%), difference in skin colour
(97%), limited active range of motion (90%), increase of complaints after exercise (89%) were inflammatory
in nature. There is evidence that free radicals are also involved in this inflammatory process since they can
damage tissue or membranes in the body. Further evidence, is that free radical scavengers like DMSO
(dimethyl sulfoxide), N-Acetyl-cysteine,or IV Mannitol are used successfully in treatment of early cases in
Holland.

==========================================================

New Guidelines Issued for Management of Hip and Knee Osteoarthritis  CME/CE
News Author: Laurie Barclay, MD
CME Author: Charles Vega, MD
posted 2/2008

Release Date: February 28, 2008; Valid for credit through February 28, 2009 Credits Available  

Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™ for physicians;
Family Physicians - up to 0.25 AAFP Prescribed credit(s) for physicians;
Nurses - 0.25 nursing contact hours (None of these credits is in the area of pharmacology)  

To participate in this internet activity: (1) review the target audience, learning objectives, and author
disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4)
view/print certificate View details.



Learning Objectives
Upon completion of this activity, participants will be able to:

List recommended nonpharmacologic treatments of osteoarthritis of the hip and knee.
Identify recommended first-line pharmacologic treatment of osteoarthritis of the hip and knee.
Authors and Disclosures
Laurie Barclay, MD
Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.



Charles Vega, MD
Disclosure: Charles Vega, MD, has disclosed an advisor/consultant relationship to Novartis, Inc.



Brande Nicole Martin
Disclosure: Brande Nicole Martin has disclosed no relevant financial information.



February 27, 2008 — The Osteoarthritis Research Society International (OARSI) has issued 25 evidence-
based, expert consensus recommendations for the management of osteoarthritis (OA) of the hip and knee.
These guidelines, which are published in the February issue of Osteoarthritis and Cartilage, were intended to
be adapted for use in different countries or regions according to the availability of treatment modalities and
strength of recommendation (SOR) for each modality of therapy.

"Osteoarthritis (OA) is the most common type of arthritis and the major cause of chronic musculoskeletal
pain and mobility disability in elderly populations worldwide," write W. Zhang, PhD, from the University of
Edinburgh, Osteoarticular Research Group, Queen's Medical Research Institute, Edinburgh, United
Kingdom. "Knee and hip pain are the major causes of difficulty in walking and climbing stairs in the elderly in
Europe and the USA and as many as 40% of people over the age of 65 in the community in the United
Kingdom suffer symptoms associated with knee or hip OA."

The objective of these guidelines was to develop concise, current, patient-centered, evidence-based, expert
consensus recommendations for the management of hip and knee OA. The panel intended these guidelines
to be adaptable and designed them as an aid to clinicians and allied healthcare professionals in general and
specialist practice throughout the world.

Goals of treatment of knee and hip OA include decreasing joint pain and stiffness, stabilizing and increasing
joint mobility, reducing physical limitations and disability, improving health-related quality of life, limiting the
progression of joint damage, and providing patient education regarding the nature and management of OA.

The medical literature has described more than 50 modalities of nonpharmacologic, pharmacologic, and
surgical therapy for knee and hip OA. Despite the development of several National and Regional Guidelines
to guide clinicians, allied healthcare professionals, and patients in their choice of treatment to manage knee
and hip OA, there have been no internationally agreed-on and universally applicable guidelines for
management.

In September 2005, OARSI convened a meeting of an international, multidisciplinary committee of experts
to critically review all existing evidence-based and consensus guidelines as well as the recent research
evidence and to develop up-to-date, evidence-based, globally relevant consensus recommendations for
management of knee and hip OA in 2007.

The guidelines development team consisted of 16 experts in primary care, rheumatology, orthopaedics, and
evidence-based medicine from the United States, the United Kingdom, France, the Netherlands, Sweden,
and Canada. Using the validated appraisal of guidelines research and evaluation instrument, the team
reviewed 23 existing guidelines published between 1945 and January 2006 and generated a core set of
management modalities based on the agreement between guidelines.

Evidence before 2002 was based on a systematic review by the European League Against Rheumatism, and
subsequent evidence was updated with use of MEDLINE, EMBASE, CINAHL, AMED, the Cochrane
Library, and health technology assessment reports. Whenever feasible, effect size (ES), number needed to
treat, relative risk or odds ratio, and cost per quality-adjusted life years gained were estimated. A Delphi
exercise was used to produce consensus recommendations, and a visual analog scale was used to determine
the SOR for propositions relating to each modality.

Of 51 treatment modalities addressed by the identified guidelines, 20 were universally recommended.
Although ES for pain relief varied among treatments, overall there was no statistically significant difference
between nonpharmacologic (0.25; 95% confidence interval [CI], 0.16 - 0.34) and pharmacologic (ES,
0.39; 95% CI, 0.31 - 0.47) modalities.

The team reached a consensus on 25 carefully worded recommendations and provided SORs and 95% CIs
for each. Their overall conclusion was that optimal management of patients with hip or knee OA requires a
combination of nonpharmacologic and pharmacologic treatment modalities.

Twelve recommendations describe the use of nonpharmacologic treatment modalities: education and self-
management; regular telephone contact with healthcare providers; physical therapy referral with provision of
canes or walkers when appropriate; aerobic, muscle-strengthening, and water-based exercises; weight loss
in overweight patients; assistive devices including walking aids, knee braces, footwear, and insoles; thermal
modalities; transcutaneous electrical nerve stimulation for short-term pain control; and acupuncture, which
may help relieve symptoms in some patients.

Eight of the recommendations discuss pharmacotherapeutic agents including acetaminophen (up to 4 g/day);
cyclooxygenase-2 (COX-2) nonselective and selective oral nonsteroidal anti-inflammatory drugs (NSAIDs)
used at the lowest effective dose, with avoidance of long-term use; topical preparations of NSAIDs and
capsaicin; intra-articular injections of corticosteroids and hyaluronates; symptomatic relief with glucosamine
and chondroitin sulphate supplementation; possible structure-modifying effects associated with glucosamine
sulphate, chondroitin sulphate, and diacerein; and indications for use of weak opioids and narcotic analgesics
to treat refractory pain.

Five recommendations focus on surgical modalities, including total joint replacements, unicompartmental
knee replacement, osteotomy and joint-preserving surgical procedures, joint lavage and arthroscopic
debridement for knee OA, and joint fusion used as a salvage procedure when joint replacement has failed.

"Patients with hip or knee OA who are not obtaining adequate pain relief and functional improvement from a
combination of non-pharmacological and pharmacological treatment should be considered for joint
replacement surgery," the authors of the guidelines write. "Replacement arthroplasties are effective, and cost-
effective interventions for patients with significant symptoms, and/or functional limitations associated with a
reduced health-related quality of life, despite conservative therapy."

OARSI provided financial support for development of these guidelines. The authors of the guidelines have
disclosed various financial relationships with such industrial entities as Abbott, AstraZeneca, Merck, Bristol-
Meyers Squibb, GlaxoSmithKline, and Novartis. The complete list of disclosures is available in the original
article.

Osteoarthr Cartil. 2008;16:137-162.

Clinical Context
OA is the most common form of arthritis, and as many as 40% of community-dwelling adults older than 65
years in the United Kingdom have symptoms associated with OA of the hip or knee. Despite the
widespread prevalence of OA, there remains controversy regarding the best management of this condition.
To address this issue, the OARSI convened 16 experts in 4 medical disciplines to review current guidelines
for the management of OA of the hip and knee. Researchers focused on guidelines published between 1945
and January 2006, and they emphasized the quality of evidence in the guidelines as well as ES, number need
to treat, and cost per quality-adjusted life years. Consensus among the expert panel was achieved following
a specific algorithm, and all current recommendations were assigned an SOR based on a scale of 0 to 100,
with a higher assigned value indicating a stronger recommendation.

The individual recommendations with their SOR values are summarized in the Study Highlights.

Study Highlights
The optimal management of OA of the hip and knee combines both nonpharmacologic and pharmacologic
treatment modalities (SOR, 96%).
The initial treatment of OA should focus on patient empowerment and self-driven therapies. All patients
should receive education on lifestyle changes, exercise, pacing of activities, and weight reduction (SOR,
97%).
Monthly telephone contact, even by lay personnel, can improve the clinical status of patients with OA (SOR,
66%).
A physical therapy consultation focusing on appropriate exercises may benefit patients with OA, although
this recommendation is largely based on expert opinion. The physical therapy visit may also include advice
regarding assistive devices for ambulation (SOR, 89%).
Weight loss is encouraged and can relieve pain and stiffness and improve function (SOR, 96%).
Assistive devices for ambulation can reduce pain associated with OA. Frames or wheeled walkers are
preferable for patients with bilateral disease (SOR, 90%).
Among patients with knee OA and mild or moderate valgus or varus instability, a knee brace can reduce
pain, improve stability, and reduce the risk of falling (SOR, 76%).
Insoles can also reduce pain among patients with knee OA (SOR, 77%).
Thermal modalities may improve knee OA, but there is less evidence that ice may be effective (SOR, 64%).
Transcutaneous electrical nerve stimulation can help with short-term pain control among patients with hip or
knee OA (SOR, 58%).
Acupuncture can relieve symptoms of knee OA (SOR, 59%).
Acetaminophen is the first choice for pharmacologic treatment of OA. Doses up to 4 g/day may be initiated
before the use of other medications (SOR, 92%).
NSAIDs may be used at their lowest effective dose, and long-term use should be avoided if possible.
Among patients at an increased risk for gastrointestinal tract bleeding, clinicians should prescribe either a
COX-2 selective agent or a nonselective NSAID with co-prescription of a proton pump inhibitor or
misoprostol. NSAIDs should be used with caution among patients with cardiovascular risk factors (SOR,
93%).
Topical NSAIDs and capsaicin can be effective as monotherapy or adjunctive treatment for OA of the knee
(SOR, 85%).
Patients with moderate to severe pain associated with knee OA that is not responding to oral therapy can be
treated with intra-articular injections (SOR, 78%).
Intra-articular injections of hyaluronate are associated with delayed onset of analgesia but a prolonged
duration of action vs injections of corticosteroids (SOR, 64%).
Treatment with glucosamine and chondroitin may relieve symptoms of OA, but treatment should be
discontinued if there is no relief after 6 months of therapy (SOR, 63%).
Unicompartmental knee replacement is effective among patients with knee OA restricted to a single
compartment (SOR, 76%).
Osteotomy may be considered for young adults with symptomatic hip OA, whereas high tibial osteotomy
may reduce the need for joint replacement among young adults with knee OA (SOR, 75%).
Joint fusion of the knee can be performed to salvage a failed joint replacement (SOR, 69%).
Pearls for Practice
The current recommendations for nonpharmacologic treatment of OA of the hip and knee include regular
telephone calls from the clinician's office; self-driven therapies; and education on lifestyle changes, exercise,
and weight reduction. For patients with knee OA, a knee brace for varus or valgus instability, insoles for
appropriate patients, acupuncture, and thermal therapy are recommended. However, the topical application
of ice is less proved.
The current guidelines for pharmacologic treatment of OA of the hip and knee recommend acetaminophen
as the first choice. Other treatments include NSAIDs and glucosamine and chondroitin, but long-term use of
these medications should be avoided.

======================================================

VITAMIN D
(OT) Scientists have developed a vitamin D pill  

Exposure to Vitamin D from sunlight is known to improve the
prognosis of certain cancers.

US drug company Novacea has produced a pill which delivers a
concentrated dose of the vitamin without running the risk of side-
effects from an overdose.

Chemistry and Industry magazine reports that if clinical trials of
the drug - Asentar (DN-101) - are successful it could be available by
2009.

The drug would be given to patients in the advanced stages of the
disease, along with chemotherapy drugs.

Professor Nick James, a cancer expert at the University of
Birmingham, said the drug had produced impressive results in
preliminary phase two trials.

He said patients taking the drug lived for an average of an extra
nine months longer than those taking another chemotherapy drug -
taxotere - alone.

Professor James said: "On average, patients in the advanced stage of
the disease survive about 18 months, so an extension of nine months
would be very significant in my view."

Asentar provides levels of vitamin D 50 to 100 times higher than
normal.

Patients would be expected to take one tablet once a week with their
weekly regime of taxotere for three weeks out of every four.

No guarantees
However, Professor James said it was far from certain that the phase
three trials would repeat the success of the earlier tests.

The phase II trial used a less than optimal taxotere regime so the
survival rate may have been artificially inflated.

Professor James said vitamin D was known to play a key role in the
regulation of several tissues, including the prostate and breast.

He said laboratory work had shown that cancer cells had lost the
ability to respond in the normal way to vitamin D, and carried on
dividing in an uncontrolled fashion.

Data shows that rates of prostate cancer are higher in countries
further away from the equator, where there is less exposure to
sunlight.

Professor James said it was possible that the new drug helped to
increase the sensitivity of cancer cells to the effect of other
chemotherapy drugs.

Dr Julie Sharp, of the charity Cancer Research UK, said: "We would
welcome any improvements in the treatment for men with advanced
prostate cancer and this drug has shown potential in early trials.

"But the results of the much larger study are needed to fully
establish if this treatment is both effective and safe."

Prostate cancer is the second leading cause of cancer death in men.
It kills one man every hour in the UK.


Source: http://news.bbc.co.uk/2/hi/health/6264533.stm


===========================================================

VARICOSE VEINS:  Reported March 7, 2008
New Help for Varicose Veins


ORLANDO, Fla. (Ivanhoe Newswire) -- Twenty-five-million Americans -- or half of all men and women
over age 50 -- have varicose veins -- veins that become damaged and fail to regulate blood flow from the
legs to the heart. They're bulging and unsightly and can lead to fatigue and pain. Now, there's a quick new
treatment for varicose veins that gets patients back to their routine faster than ever.



Lately it's been Amelia the dog doing all the dancing at Dave Schwartzman's house. He says his left leg often
feels tired and heavy. The reason: varicose veins.



Schwartzman is undergoing a new procedure to treat the problem. It's all done under local anesthesia.
Vascular surgeon Dr. Ken Adcock uses ultrasound to go inside the vein with a catheter, then a radio
frequency probe.



Radio frequency energy is used to heat the vein from inside, causing the vein wall to contract and close. This
redirects the blood to other healthy veins. The treatment takes just a few minutes and Dr. Adcock says it's
also easier on the patient.



"It's a lot less traumatic to surrounding tissues a lot better as far as patient comfort," says G. Kendrix
Adcock, M.D., a vascular surgeon at Florida Vascular Consultants in Orlando, Fla.



Other varicose vein treatments, like laser or vein stripping, can leave bruises that can last for days. But with
this procedure, Dr. Adcock says there's virtually no bruising or pain, and patients can return to regular
activities in just 48 hours.



"I've been performing vascular surgeries for almost 25 years now and this is a quantum leap forward," Dr.
Adcock says.



"I was surprised at how quick it took, and really pain free and that's not an exaggeration it was pain free,"
Schwartzman says.



Doctors aren't sure what causes varicose veins. They do know the condition runs in families, and is more
common in women and men. Also varicose veins seem to occur more often in people who spend many
hours a day on their feet.



FOR MORE INFORMATION, PLEASE CONTACT:



VNUS ClosureFAST

http://www.vnus.com



Florida Vascular Consultants

http://www.flvascular.com